Insider Trading - Tilton John
Real time insider trading transaction history:
- Insiders must file a Form 4 covering their trades within two business days.
- Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2017-11-01 Sale | 2017-11-02 5:55 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 30,000 | $29.25 | $877,586 | 90,406 (Indirect Direct) | View |
| 2019-01-10 Sale | 2019-01-14 5:50 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,500 | $37.67 | $395,535 | 12,114 (Indirect Direct) | View |
| 2019-03-12 Sale | 2019-03-14 5:51 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,000 | $50.11 | $501,100 | 80,406 (Indirect Direct) | View |
| 2020-06-10 Sale | 2020-06-12 5:19 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 52,000 | $67.38 | $3,504,001 | 38,062 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2017-05-09 Conversion | 2017-05-11 5:33 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 1,614 | $0 | 1,614 (Indirect) | View |
| 2017-11-01 Exercise | 2017-11-02 5:55 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 30,000 | $9.29 | 90,406 (Direct) | View |
| 2017-11-01 Exercise | 2017-11-02 5:55 pm | N/A 2027-01-30 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 30,000 | $0 | 90,406 (Direct) | View |
| 2017-12-07 Option Award | 2017-12-11 5:37 pm | N/A 2027-12-06 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 21,740 | $0 | 21,740 (Direct) | View |
| 2019-01-10 Exercise | 2019-01-14 5:50 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,500 | $9.29 | 12,114 (Direct) | View |
| 2019-01-10 Exercise | 2019-01-14 5:50 pm | N/A 2026-12-14 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,500 | $0 | 12,114 (Direct) | View |
| 2019-03-12 Exercise | 2019-03-14 5:51 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,000 | $9.29 | 80,406 (Direct) | View |
| 2019-03-12 Exercise | 2019-03-14 5:51 pm | N/A 2027-01-30 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,000 | $0 | 80,406 (Direct) | View |
| 2019-11-25 Option Award | 2019-11-27 9:31 pm | N/A 2029-11-24 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John CCO-Rare & Neurologic Disorder | 15,000 | $0 | 15,000 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 9:41 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John CCO-Rare & Neurologic Disorder | 1,250 | $0 | 6,134 (Direct) | View |
| 2019-12-18 Tax Withholding | 2019-12-20 9:41 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John CCO-Rare & Neurologic Disorder | 480 | $52.13 | 6,134 (Direct) | View |
| 2020-06-10 Exercise | 2020-06-12 5:19 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 52,000 | $9.29 | 38,062 (Direct) | View |
| 2020-06-10 Exercise | 2020-06-12 5:19 pm | N/A 2027-01-30 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 52,000 | $0 | 38,062 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-27 9:48 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 1,250 | $0 | 5,654 (Direct) | View |
| 2020-11-25 Tax Withholding | 2020-11-27 9:48 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 480 | $90.14 | 5,654 (Direct) | View |
| 2021-01-06 Exercise | 2021-01-08 8:49 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 1,250 | $0 | 23,023 (Direct) | View |
| 2021-01-06 Option Award | 2021-01-08 8:49 pm | N/A 2031-01-06 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 15,000 | $0 | 23,023 (Direct) | View |
| 2021-01-06 Tax Withholding | 2021-01-08 8:49 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 492 | $83.38 | 23,023 (Direct) | View |
| 2021-11-25 Exercise | 2021-11-26 4:33 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 1,250 | $0 | 6,281 (Direct) | View |
| 2021-11-25 Tax Withholding | 2021-11-26 4:33 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 492 | $115.55 | 6,281 (Direct) | View |